{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:40:16Z","timestamp":1774485616908,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s12035-015-9209-z","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T03:10:46Z","timestamp":1432609846000},"page":"3124-3135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["LRRK2 Promotes Tau Accumulation, Aggregation and Release"],"prefix":"10.1007","volume":"53","author":[{"given":"Patr\u00edcia Silva","family":"Guerreiro","sequence":"first","affiliation":[]},{"given":"Ellen","family":"Gerhardt","sequence":"additional","affiliation":[]},{"given":"Tom\u00e1s","family":"Lopes da Fonseca","sequence":"additional","affiliation":[]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[]},{"given":"Tiago Fleming","family":"Outeiro","sequence":"additional","affiliation":[]},{"given":"Katrin","family":"Eckermann","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"issue":"4","key":"9209_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u00edz","year":"2004","unstructured":"Pais\u00e1n-Ru\u00edz C et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44(4):595\u2013600","journal-title":"Neuron"},{"issue":"4","key":"9209_CR2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601\u20137","journal-title":"Neuron"},{"issue":"46","key":"9209_CR3","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB et al (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102(46):16842\u20137","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"9209_CR4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1474-4422(11)70175-2","volume":"10","author":"OA Ross","year":"2011","unstructured":"Ross OA et al (2011) Association of LRRK2 exonic variants with susceptibility to Parkinson\u2019s disease: a case-control study. Lancet Neurol 10(10):898\u2013908","journal-title":"Lancet Neurol"},{"issue":"12","key":"9209_CR5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease. Nat Rev Neurosci 11(12):791\u20137","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"9209_CR6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1042\/BST20120054","volume":"40","author":"E Greggio","year":"2012","unstructured":"Greggio E (2012) Role of LRRK2 kinase activity in the pathogenesis of Parkinson\u2019s disease. Biochem Soc Trans 40(5):1058\u201362","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"9209_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio E et al (2006) Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol Dis 23(2):329\u201341","journal-title":"Neurobiol Dis"},{"issue":"10","key":"9209_CR8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9(10):1231\u20133","journal-title":"Nat Neurosci"},{"issue":"3","key":"9209_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bies.200900163","volume":"32","author":"JM Taymans","year":"2010","unstructured":"Taymans JM, Cookson MR (2010) Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, alpha-synuclein, and tau. Bioessays 32(3):227\u201335","journal-title":"Bioessays"},{"issue":"5","key":"9209_CR10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1042\/BST20120124","volume":"40","author":"E Belluzzi","year":"2012","unstructured":"Belluzzi E, Greggio E, Piccoli G (2012) Presynaptic dysfunction in Parkinson\u2019s disease: a focus on LRRK2. Biochem Soc Trans 40(5):1111\u20136","journal-title":"Biochem Soc Trans"},{"key":"9209_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.81","volume":"2","author":"M Lichtenberg","year":"2011","unstructured":"Lichtenberg M, Mansilla A, Zecchini VR, Fleming A, Rubinsztein DC (2011) The Parkinson\u2019s disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity. Cell Death Dis 2, e196","journal-title":"Cell Death Dis"},{"issue":"4","key":"9209_CR12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3(4):519\u201326","journal-title":"Neuron"},{"issue":"50","key":"9209_CR13","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1021\/bi401266n","volume":"52","author":"M Schwalbe","year":"2013","unstructured":"Schwalbe M et al (2013) Phosphorylation of human Tau protein by microtubule affinity-regulating kinase 2. Biochemistry 52(50):9068\u201379","journal-title":"Biochemistry"},{"issue":"5","key":"9209_CR14","first-page":"595","volume":"13","author":"PJ Dolan","year":"2010","unstructured":"Dolan PJ, Johnson GV (2010) The role of tau kinases in Alzheimer\u2019s disease. Curr Opin Drug Discov Devel 13(5):595\u2013603","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"12","key":"9209_CR15","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","volume":"98","author":"A Alonso","year":"2001","unstructured":"Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments. Proc Natl Acad Sci U S A 98(12):6923\u20138","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9209_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fneur.2013.00122","volume":"4","author":"AS Chesser","year":"2013","unstructured":"Chesser AS, Pritchard SM, Johnson GV (2013) Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer Disease. Front Neurol 4:122","journal-title":"Front Neurol"},{"key":"9209_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","volume":"105","author":"MJ Lee","year":"2013","unstructured":"Lee MJ, Lee JH, Rubinsztein DC (2013) Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105:49\u201359","journal-title":"Prog Neurobiol"},{"issue":"6","key":"9209_CR18","first-page":"561","volume":"2","author":"T Hamano","year":"2009","unstructured":"Hamano T, Gendron TF, Ko LW, Yen SH (2009) Concentration-dependent effects of proteasomal inhibition on tau processing in a cellular model of tauopathy. Int J Clin Exp Pathol 2(6):561\u201373","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"9209_CR19","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.neurobiolaging.2011.11.009","volume":"33","author":"U Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger U, Wang Y, Kumar S, Mandelkow EM (2012) Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging 33(10):2291\u2013305","journal-title":"Neurobiol Aging"},{"key":"9209_CR20","doi-asserted-by":"crossref","unstructured":"Moreau K\u00a0et al (2014) PICALM modulates autophagy activity and tau accumulation. Nat Commun 22(5):4998","DOI":"10.1038\/ncomms5998"},{"issue":"1","key":"9209_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030834","volume":"7","author":"F Kawakami","year":"2012","unstructured":"Kawakami F et al (2012) LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth. PLoS One 7(1), e30834","journal-title":"PLoS One"},{"issue":"1","key":"9209_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/febs.12579","volume":"281","author":"F Kawakami","year":"2014","unstructured":"Kawakami F et al (2014) Leucine-rich repeat kinase\u00a02 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3\u03b2. FEBS J 281(1):3\u201313","journal-title":"FEBS J"},{"issue":"6","key":"9209_CR23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-013-1188-4","volume":"126","author":"RM Bailey","year":"2013","unstructured":"Bailey RM et al (2013) LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol 126(6):809\u201327","journal-title":"Acta Neuropathol"},{"issue":"11","key":"9209_CR24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tibs.2010.05.007","volume":"35","author":"SA Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves SA, Matos JE, Outeiro TF (2010) Zooming into protein oligomerization in neurodegeneration using BiFC. Trends Biochem Sci 35(11):643\u201351","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"9209_CR25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38(10):1184\u201391","journal-title":"Nat Genet"},{"issue":"2-3","key":"9209_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000355654","volume":"13","author":"S Saha","year":"2014","unstructured":"Saha S, Liu-Yesucevitz L, Wolozin B (2014) Regulation of autophagy by LRRK2 in Caenorhabditis elegans. Neurodegener Dis 13(2-3):110\u20133","journal-title":"Neurodegener Dis"},{"key":"9209_CR27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0076-6879(05)99033-2","volume":"399","author":"NF Bence","year":"2005","unstructured":"Bence NF, Bennett EJ, Kopito RR (2005) Application and analysis of the GFPu family of ubiquitin-proteasome system reporters. Methods Enzymol 399:481\u201390","journal-title":"Methods Enzymol"},{"key":"9209_CR28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0076-6879(05)98030-0","volume":"398","author":"AF Kisselev","year":"2005","unstructured":"Kisselev AF, Goldberg AL (2005) Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol 398:364\u201378","journal-title":"Methods Enzymol"},{"issue":"3","key":"9209_CR29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T et al (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382\u20139","journal-title":"Arch Neurol"},{"issue":"4","key":"9209_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00109-012-0984-y","volume":"91","author":"PS Guerreiro","year":"2013","unstructured":"Guerreiro PS et al (2013) LRRK2 interactions with \u03b1-synuclein in Parkinson\u2019s disease brains and in cell models. J Mol Med (Berl) 91(4):513\u201322","journal-title":"J Mol Med (Berl)"},{"issue":"22","key":"9209_CR31","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1093\/hmg\/ddp394","volume":"18","author":"K Venderova","year":"2009","unstructured":"Venderova K et al (2009) Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson\u2019s disease. Hum Mol Genet 18(22):4390\u2013404","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9209_CR32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","volume":"430","author":"RJ Nichols","year":"2010","unstructured":"Nichols RJ et al (2010) 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson\u2019s disease-associated mutations and regulates cytoplasmic localization. Biochem J 430(3):393\u2013404","journal-title":"Biochem J"},{"key":"9209_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12798","author":"L Reyniers","year":"2014","unstructured":"Reyniers L et al (2014) Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways. J Neurochem. doi: 10.1111\/jnc.12798","journal-title":"J Neurochem"},{"issue":"3","key":"9209_CR34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","volume":"40","author":"HL Melrose","year":"2010","unstructured":"Melrose HL et al (2010) Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 40(3):503\u201317","journal-title":"Neurobiol Dis"},{"issue":"7","key":"9209_CR35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2009.03.008","volume":"34","author":"D Matenia","year":"2009","unstructured":"Matenia D, Mandelkow EM (2009) The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem Sci 34(7):332\u201342","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"9209_CR36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036581","volume":"7","author":"MC Herzig","year":"2012","unstructured":"Herzig MC et al (2012) High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain. PLoS One 7(5), e36581","journal-title":"PLoS One"},{"issue":"8","key":"9209_CR37","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jnr.21622","volume":"86","author":"PN Gandhi","year":"2008","unstructured":"Gandhi PN, Wang X, Zhu X, Chen SG, Wilson-Delfosse AL (2008) The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res 86(8):1711\u201320","journal-title":"J Neurosci Res"},{"issue":"44","key":"9209_CR38","doi-asserted-by":"crossref","first-page":"13971","DOI":"10.1523\/JNEUROSCI.3799-09.2009","volume":"29","author":"L Parisiadou","year":"2009","unstructured":"Parisiadou L et al (2009) Phosphorylation of ezrin\/radixin\/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 29(44):13971\u201380","journal-title":"J Neurosci"},{"issue":"2","key":"9209_CR39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1074\/jbc.M113.507913","volume":"289","author":"BM Law","year":"2014","unstructured":"Law BM et al (2014) A direct interaction between leucine-rich repeat kinase 2 and specific \u03b2-tubulin isoforms regulates tubulin acetylation. J Biol Chem 289(2):895\u2013908","journal-title":"J Biol Chem"},{"issue":"5","key":"9209_CR40","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1471-4159.2009.06235.x","volume":"110","author":"F Gillardon","year":"2009","unstructured":"Gillardon F (2009) Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability\u2014a point of convergence in parkinsonian neurodegeneration? J Neurochem 110(5):1514\u201322","journal-title":"J Neurochem"},{"issue":"1","key":"9209_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","volume":"85","author":"S Keck","year":"2003","unstructured":"Keck S, Nitsch R, Grune T, Ullrich O (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer\u2019s disease. J Neurochem 85(1):115\u201322","journal-title":"J Neurochem"},{"issue":"5619","key":"9209_CR42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300(5619):636\u201340","journal-title":"Science"},{"issue":"4","key":"9209_CR43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-130413","volume":"37","author":"MP Chaunu","year":"2013","unstructured":"Chaunu MP et al (2013) Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R. J Alzheimers Dis 37(4):769\u201376","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"9209_CR44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1471-4159.2002.01137.x","volume":"83","author":"DC David","year":"2002","unstructured":"David DC et al (2002) Proteasomal degradation of tau protein. J Neurochem 83(1):176\u201385","journal-title":"J Neurochem"},{"issue":"4","key":"9209_CR45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1042\/BST20120071","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang Y, Mandelkow E (2012) Degradation of tau protein by autophagy and proteasomal pathways. Biochem Soc Trans 40(4):644\u201352","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"9209_CR46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbrc.2013.10.159","volume":"441","author":"C Manzoni","year":"2013","unstructured":"Manzoni C et al (2013) Pathogenic Parkinson\u2019s disease mutations across the functional domains of LRRK2 alter the autophagic\/lysosomal response to starvation. Biochem Biophys Res Commun 441(4):862\u20136","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"9209_CR47","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","volume":"105","author":"ED Plowey","year":"2008","unstructured":"Plowey ED, Cherra SJ 3rd, Liu YJ, Chu CT (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105(3):1048\u201356","journal-title":"J Neurochem"},{"issue":"7","key":"9209_CR48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1248\/bpb.34.1078","volume":"34","author":"K Kondo","year":"2011","unstructured":"Kondo K, Obitsu S, Teshima R (2011) \u03b1-Synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells. Biol Pharm Bull 34(7):1078\u201383","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"9209_CR49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.febslet.2011.11.022","volume":"586","author":"D Sim\u00f3n","year":"2012","unstructured":"Sim\u00f3n D, Garc\u00eda-Garc\u00eda E, Royo F, Falc\u00f3n-P\u00e9rez JM, Avila J (2012) Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett 586(1):47\u201354","journal-title":"FEBS Lett"},{"issue":"23","key":"9209_CR50","doi-asserted-by":"crossref","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","volume":"287","author":"N Kfoury","year":"2012","unstructured":"Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI (2012) Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem 287(23):19440\u201351","journal-title":"J Biol Chem"},{"issue":"24","key":"9209_CR51","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1093\/hmg\/ddt346","volume":"22","author":"KB Fraser","year":"2013","unstructured":"Fraser KB et al (2013) LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet 22(24):4988\u20135000","journal-title":"Hum Mol Genet"},{"issue":"21","key":"9209_CR52","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/sj.emboj.7600426","volume":"23","author":"CI Holmberg","year":"2004","unstructured":"Holmberg CI et al (2004) Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J 23(21):4307\u201318","journal-title":"EMBO J"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9209-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9209-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T10:53:26Z","timestamp":1566730406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9209-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9209"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9209-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}